A Smart + Strong Site
Subscribe to:
E-newsletters
POZ magazine
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Treatment News » Top Stories

Most Popular Stories
Post-Conference Report Provides HIV Cure Roadmap
Life Expectancy With HIV Increases Dramatically
Improper Use of a Neti Pot Can Be Fatal
Animal Studies Suggest Anti-Reservoir Drugs May Help 'Functionally Cure' HIV
Tenofovir Microbicide Gel Falters in Major HIV Prevention Study
Gold Drug Shows HIV Eradication Potential
New Studies Under Way of Sangamo's Possible 'Functional Cure' Gene Therapy
What's That Mean?
(just double-click it!)

If you don't understand one of the words in this article, just double-click it. A window will open with a definition from mondofacto's On-line Medical Dictionary. If the double-click feature doesn't work in your browser, you can enter the word below:

Most Popular Lessons
Aging & HIV
The HIV Life Cycle
Shingles
Herpes Simplex Virus
Syphilis & Neurosyphilis
Treatments for Opportunistic Infections (OIs)
What is AIDS & HIV?
More News

Have medical or treatment news about HIV? Send press releases, news tips and other announcements to editors@aidsmeds.com.

Click here for more news


emailrssprint

April 29, 2009

Prezista Levels in the Brain High Enough to Control HIV

Levels of the protease inhibitor (PI) Prezista (darunavir) are high enough in cerebrospinal fluid (CSF) to control HIV reproduction in the brain, according to a study published in the April issue of AIDS Research and Human Retroviruses. Suppressing HIV in the brain may help prevent thinking and memory problems as people living with the virus age, though this has not been proved in clinical trials.

Studies presented this past winter at the 16th Conference on Retroviruses and Opportunistic Infections make clear that cognitive problems are a common and growing concern in people with HIV, especially as they get older.  Some experts studying HIV activity in the brain recommend people with cognitive problems—or who are at risk for them, such as people also dealing with diabetes or hepatitis C—include in their regimens antiretroviral (ARV) medications proved to penetrate the brain.

Because of a barrier between the blood stream and the brain, however, not all ARV drugs reach the central nervous system (CNS). PIs typically have the most difficult time getting into the CNS. But combined with Norvir (ritonavir)—low doses of Norvir increase concentrations of other PIs in the body—they achieve much better penetration.  

To determine brain penetration with Norvir-boosted Prezista—one of the newest PIs that haven’t been studied fully for CNS penetration potential—Aylin Yilmaz, PhD, from the University of Gothenburg in Sweden, and her colleagues compared blood and CSF levels of the drug in eight HIV-positive patients. In all, the authors compared 14 paired samples.

Yilmaz’s team found that Prezista was detectable in all CSF samples. What’s more, the researchers demonstrated, Prezista levels were within or exceeded the range necessary to control HIV reproduction in the majority of samples.

“[It is] probable that [Prezista], at least to some extent, contributes to the suppression of HIV replication in the central nervous system,” Yilmaz’s group concludes.

Search: Prezista, darunavir, Norvir, ritonavir, protease inhibitor, brain barrier, central nervous system, CNS, cerebrospinal fluid, CSF, Aylin Yilmaz


Scroll down to comment on this story.

emailrssprint

Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The AIDSmeds team review all comments before they are posted. Please do not include ":" "@" "<" ">" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

| Posting Rules

Previous Comments:

       


[Go to top]

Quick Links
AIDSmeds en Español
About HIV and AIDS
Lab Tests
Clinical Trials
HIV Meds
Starting Treatment
Switching Treatment
Drug Resistance
Side Effects
Disclosure
Lipodystrophy
Hepatitis & HIV
Women & Children
Fact Sheets
Treatment News
Community Forums
Blogs
Conference Coverage
Health Services Directory
POZ Magazine


    bigmama41
    greensboro
    North Carolina


    Savannahman78
    Topeka
    Kansas


    5665150
    Phoenix
    Arizona


    flowrider
    Dallas
    Texas
Click here to join POZ Personals!
Conference Coverage

6th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2011)
Rome, Italy
July 17 - 20, 2011


18th Conference on Retroviruses and Opportunistic Infections (CROI 2011)
Boston, MA
February 27 - March 2, 2011


XVIII International AIDS Conference
Vienna, Austria
July 18-23, 2010

more conference coverage


[ about AIDSmeds | AIDSmeds advisory board | our staff | advertising policy | advertise/contact us]
© 2012 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.